Adam S. Grossman, President,CEO, and Interim CFO: Adma Biologics ADMA Sell · Filed 24/06/14

Trade details

Type: Insider sale
Amount: $1,072,000
Shares · price: 100,000 sh · $10.72 a share
Held after: 2,081,475 sh
Stock: Adma Biologics ADMA
Person: Adam S. GrossmanPresident,CEO, and Interim CFO
Trade date: 24/06/14
Filed: 24/06/14
Days to filing: 0 days

Sold 4.6% of holdings

Share of holding sold: 4.6%

Adma Biologics trades, last 26 weeks

What else happened in Adma Biologics around then

Filed or reported within 30 days of the trade day · 24/05/15~24/07/14

Adam S. Grossman's recent trades

Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$227.4K
15,000 sh
$227.4K
Filed 03/17
Traded 03/16
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$91K
6,000 sh
$91K
Filed 03/17
Traded 03/16
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$241.2K
15,000 sh
$241.2K
Filed 02/17
Traded 02/17
Adam S. GrossmanPresident and CEO
Sell10b5-1 planAdma Biologics
Sell10b5-1 plan
Adma Biologics
ADMA
$96.5K
6,000 sh
$96.5K
Filed 02/17
Traded 02/17
Adam S. GrossmanPresident and CEO
Planned saleAdma Biologics
Planned sale
Adma Biologics
ADMA
$2M
125,000 sh
$2M
Filed 02/17
Traded 02/17

Adam S. Grossman, CEO — sold $1.1M of Adma Biologics ADMA · 4.6% of holdings | Whalegun